Calcium channel blockers for preventing acute tubular necrosis in kidney transplant recipients

Author(s):  
IR Shilliday ◽  
M Sherif
1999 ◽  
Vol 3 (4) ◽  
pp. 288-292 ◽  
Author(s):  
Douglas M. Silverstein ◽  
JoAnn Palmer ◽  
H. Jorge Baluarte ◽  
Caroline Brass ◽  
Susan B. Conley ◽  
...  

2019 ◽  
Vol 12 (5) ◽  
pp. e229587 ◽  
Author(s):  
Tarun Nanda ◽  
Baljeet Singh ◽  
Parul Sharma ◽  
Karandeep Singh Arora

Drug-induced gingival overgrowth is a condition caused by side effects of treatment with one of three types of drugs: phenytoin (used in epilepsy treatment), cyclosporine A (used in transplantology after allogenic organ transplants) and calcium channel blockers (used in the treatment of hypertension). Gingival overgrowth leads to inflammation within the gums and periodontium and can amplify the existing periodontal disease leading to tooth loss. Patients who have undergone kidney transplant are given immunosuppressants to prevent transplant rejection and mostly it is accompanied with calcium channel blockers to treat hypertension associated with kidney transplant. This article reports a case of recent gingival enlargement associated with cyclosporine A and amlodipine given to a kidney transplant patient from the past 11 years.


2019 ◽  
Vol 2 (2) ◽  
pp. 259-264
Author(s):  
Swosti Thapa ◽  
Robin Bahadur Basnet ◽  
Bikal Shrestha ◽  
Amresh Thakur ◽  
Neesha Shrestha ◽  
...  

Gingival Overgrowth is a known and common complication with multifactorial etiology seen in kidney transplant recipients. Gingival Overgrowth is induced in kidney transplant recipients by Cyclosporin A and Calcium Channel Blockers that are frequently prescribed to them as immunosuppressive and antihypertensive, respectively. There have been 1477 kidney transplantations in Nepal since the first kidney transplantation in 2008, but cases of gingival Overgrowth have not been reported in any publications. The aim of this review is to discuss the different aspects of gingival Overgrowth and its relevance to kidney transplant recipients of Nepal. This review will emphasize the need to examine the oral cavity of kidney transplant recipients. Genetic predisposition, oral health, and offending drugs are involved in the pathogenesis of gingival Overgrowth. This review discusses the pathogenesis, clinical features, and management aspects of gingival Overgrowth in kidney transplantation recipients. The reason for gingival Overgrowth not being reported in Nepal could be due to various reasons like favorable genes, good oral hygiene, or avoidance of drugs that cause gingival Overgrowth in kidney transplantation recipients. This could also be due to gingival Overgrowth being ignored by the patients and the treating doctors. These aspects are reviewed with reference to previous publications.


Sign in / Sign up

Export Citation Format

Share Document